In the past two decades, IDH mutation, MGMT promoter methylation, TERT promoter mutation, RTK, PI3K and p53 pathways alterations, molecular subtype and G-CIMP phenotype were identified to play crucial roles in the pathogenesis of GBM and also be of prognostic value 6-17. This evidence concerns the gene IDH1 and glioblastoma.